Last updated 2026-07-20
- Raised $2M Seed round, Dec 2020
Total raised
$2.0M
Last: Undisclosed Round 2021-01
Stage
Seed
Founded
2019
Headcount
6
HQ
Givatayim, Israel
Sector
Health Tech & Life Sciences
About
Elixie is an Israeli biotech startup focused on providing symptomatic relief for chronic conditions by leveraging nano-drug delivery technology to develop innovative and inclusive medicinal cannabis products. The company's core technology, NANOLIX, is a high-absorption drug-delivery system that encapsulates cannabinoids in nanoemulsions, clinically proven to promote fast, efficient, and consistent absorption. Elixie was founded in 2019 and has its headquarters in Givatayim, Israel, with an R&D lab in Caesarea.
Funding history · 1 round · $2.0M total
2020-12
Seed
$2.0M
Headcount over time
From 3 (2020-07) to 6 (2025-10) · +3 (+100%) · 19 points · source: Finder history + radar grounding
Q&A
- What is Elixie's primary focus?
- Elixie is a clinical-stage biotech company focused on enhancing cannabinoids for symptomatic relief of neurological disorders, utilizing its patented NANOLIX drug delivery system.
- When was Elixie founded?
- Elixie was founded in October 2019.
- What is Elixie's total funding to date?
- Elixie has raised a total of $2,000,000 USD.
- When did Elixie complete its last funding round?
- Elixie completed its last funding round in January 2021, raising $2,000,000 USD.
- What is Elixie's current employee count?
- Elixie currently has 1-10 employees.
- Who is the co-founder and CEO of Elixie?
- Yaron Shoob is the Co-founder & CEO of Elixie.
- What is Elixie's primary sector classification?
- Elixie's primary sector is Health Tech & Life Sciences.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
chronic-painnanotechnologymultiple-sclerosisdrug-deliverycannabispharma-companiesmedical-technologiespharmaceuticalsepilepsychronic-diseasemedical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | elixie.com |
|---|---|
| linkedin.com/company/64527214 |
Identifiers & details
| Legal name | Elixie, Ltd. |
|---|---|
| Former names | Aset Dev Ltd |
| Founded | 2019 |
| Employees (exact) | 6 |
| Offices | Giv'atayim |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | elixie.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516097417 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-10-27 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — shares_capital (1) |
| Registered address | חפץ ישה 1 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-07-01 | הקצאת מניות |